drugset / Trial / NCT03472014
Special Access Program IMVAMUNE®
NaSingle-groupOpen-labelPrevention
Summary
Prophylactic smallpox vaccination for personnel actively working with or in the vicinity of replicating vaccinia virus
Timeline
- Start
- 2010-04-22
- Primary completion
- 2014-11-14
- Completion
- 2014-11-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMVAMUNE | Vaccine | 0.5 ml | Subcutaneous |
Indications
No indication recorded.